- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01640977
A Prospective Non-concurrent Controlled Evaluation of Open and MAS® PLIF
April 29, 2015 updated by: NuVasive
A Prospective Non-current Concurrent Controlled Evaluation of Open and MAS® PLIF for the Treatment of Symptomatic Lumbar Degenerative Conditions
The study is a prospective non-concurrent controlled observational evaluation of short-term operative results.
As such, study sites will capture perioperative (through 6-week postoperative follow-up) case data associated with 10 standard open PLIF (posterior lumbar interbody fusion) procedures.
After this open experience, these same sites will capture the corresponding data from 10 subsequent cases where the MAS (Maximum Access Surgery) PLIF variant was performed.
The data from both series of cases will be compiled to identify similarities and differences between the techniques.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The objective of this evaluation is to collect and compare short-term factors related to the morbidity of approach using traditional posterior-approach interbody fusion techniques and a less invasive exposure for the same procedure.
Perioperative measures and early outcomes will be documented to demonstrate differences in procedural requirements, safety, and early recovery.
A total of 100 subjects will be consecutively enrolled in this prospective study from as many as 8 centers.
Patients who, in the surgeon investigator's opinion, require instrumented lumbar interbody fusion and have consented to PLIF surgery for their conditions will be included.
The following eligibility criteria are designed to identify existing clinic patients for whom study under this protocol is considered appropriate.
All subjects must meet the inclusion/exclusion criteria in order to be considered for enrollment.
Study Type
Observational
Enrollment (Actual)
67
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Greensboro, North Carolina, United States, 27401
- Kuether Brain and Spine
-
Greensboro, North Carolina, United States, 27401
- Nova Neurosurgical Brain and Spine
-
-
Pennsylvania
-
York, Pennsylvania, United States, 17405
- WellSpan Orthopedics-York
-
-
Texas
-
Temple, Texas, United States, 76508
- Scott and White Healthcare
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Existing clinic patients
Description
Inclusion Criteria:
Subjects must meet all inclusion criteria to be eligible for enrollment into this observational study:
- Indicated for posterior lumbar interbody fusion at one or two contiguous motion segments between L1 and S1;
- 18+ years of age at the date of written informed consent;
- Able to undergo surgery based on physical exam, medical history and surgeon judgment;
- Willing and able to return for post-treatment exams according to the follow-up called for in the protocol;
Signed and dated informed consent form.
Exclusion Criteria:
Subjects presenting with any of the following will not be included in this observational study:
- Mental or physical condition that would limit the ability to comply with study requirements;
- Spine abnormality requiring treatment at more than two levels;
- Prior surgery at operative or adjacent level(s);
- Involvement in active litigation relating to the spine (worker's compensation claim is allowed if it is not contested);
- Significant general illness (e.g., HIV, active metastatic cancer of any type, uncontrolled diabetes, dialysis dependent renal failure, symptomatic liver disease);
- Participating in another clinical study that would confound study data.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Open PLIF
The PLIF procedure achieves access to the degenerated disc from the back of the spine, and is performed through a single midline posterior incision that is typically expanded bilaterally past the facet joints to expose bony landmarks for pedicle screw fixation, which are traditionally placed in a trajectory from lateral to medial, requiring a more lateral starting point.
|
The PLIF procedure achieves access to the degenerated disc from the back of the spine.
|
MAS PLIF
The MAS PLIF technique is a minimally invasive variant of the traditional PLIF procedure.
It is similarly performed through a single midline posterior incision but is conducted through a more medialized posterior approach, avoiding the far lateral exposure typical of the traditional PLIF.
|
The MAS PLIF technique is a minimally invasive variant of the traditional PLIF procedure.
It is similarly performed through a single midline posterior incision but is conducted through a more medialized posterior approach.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Complications
Time Frame: 6-weeks
|
All complications will be compiled and their incidence and relationship to the product and/or surgical procedure will be tabulated for comparison.
|
6-weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical Outcomes
Time Frame: 6-weeks
|
Visual analog scale (for patient self assessment of back/leg pain)
|
6-weeks
|
Radiographic Outcomes
Time Frame: 6-weeks
|
Radiographic assessment (AP/lateral x-rays)
|
6-weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Kelli Howell, MS, NuVasive
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Actual)
June 1, 2014
Study Completion (Actual)
September 1, 2014
Study Registration Dates
First Submitted
July 9, 2012
First Submitted That Met QC Criteria
July 11, 2012
First Posted (Estimate)
July 16, 2012
Study Record Updates
Last Update Posted (Estimate)
April 30, 2015
Last Update Submitted That Met QC Criteria
April 29, 2015
Last Verified
April 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NUVA.P1001
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lumbar Degenerative Disc Disease
-
NuVasiveCompleted
-
NuVasiveCompleted
-
Spine BioPharma, IncMCRARecruitingLumbar Degenerative Disc DiseaseUnited States
-
Synthes USA HQ, Inc.CompletedLumbar Degenerative Disc Disease
-
Assistance Publique - Hôpitaux de ParisTerminatedCervical Degenerative Disc Disease | Kyphosis | Lumbar Degenerative Disc DiseaseFrance
-
NYU Langone HealthActive, not recruitingLumbar Degenerative Disc DiseaseUnited States
-
Bioventus LLCTerminatedLumbar Degenerative Disc Disease
-
Justin Parker Neurological InstituteTerminated
-
OAD OrthopaedicsCentral DuPage Hospital; Halifax Biomedical Inc.Unknown
-
Eisai China Inc.Completed
Clinical Trials on Open PLIF (posterior lumbar interbody fusion)
-
Jos M. A. KuijlenNot yet recruitingDegenerative Spondylolisthesis | Spondylolytic Spondylolisthesis
-
ExactechTerminatedDegenerative Disc Disease | Spondylolisthesis | StenosisUnited States
-
Assiut UniversityCompletedLumbar Spine FusionEgypt
-
Spine and Scoliosis Research AssociatesEnrolling by invitationDegenerative Disc Disease (DDD)United States
-
The London Spine CentreUnknownDegenerative Lumbar SpondylolisthesisCanada
-
AOSpine North America Research NetworkCompletedIsthmic SpondylolisthesisUnited States, Canada
-
The London Spine CentreUnknownSpinal Stenosis | Degenerative SpondylolisthesisCanada
-
Assiut UniversityUnknown
-
Premia SpineActive, not recruitingLumbar Spinal Stenosis | Degenerative SpondylolisthesisUnited States
-
Justin Parker Neurological InstituteCompletedDegenerative Disc DiseaseUnited States